🔎 Trials Near Me

Inicio › Neuroblastoma › Georgia

Ensayos clínicos de Neuroblastoma en Georgia

9 estudios sobre Neuroblastoma buscan participantes en Georgia.

Ciudades en Georgia

Texto oficial del estudio (inglés)

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

  • Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
  • Memorial Health University Medical Center, Savannah
ReclutandoFase 3
Hasta los 30 · Todos los sexos · Actualizado el 24 sept 2026 · NCT06172296

Pediatric Precision Laboratory Advanced Neuroblastoma Therapy

  • Augusta University Health, Augusta
ReclutandoFase 2
Hasta los 22 · Todos los sexos · Actualizado el 4 sept 2026 · NCT02559778

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

  • Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
  • Memorial Health University Medical Center, Savannah
ReclutandoFase 3
365 Days – 30 Years · Todos los sexos · Actualizado el 25 ago 2026 · NCT03126916

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

  • Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
ReclutandoFase 1/2
12 Months – 30 Years · Todos los sexos · Actualizado el 25 ago 2026 · NCT04851119

Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma

  • Augusta University Health, Augusta
ReclutandoFase 2
12 Months – 21 Years · Todos los sexos · Actualizado el 12 ago 2026 · NCT05489887

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

  • Children's Healthcare of Atlanta/Emory University School of Medicine, Atlanta
ReclutandoFase 1/2
12 Months – 30 Years · Todos los sexos · Actualizado el 19 may 2026 · NCT04901702

Neuroblastoma Biology Study

  • AFLAC Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta - Egleston Campus, Atlanta
ReclutandoEstudio observacional
31 Days – 99 Years · Todos los sexos · Actualizado el 23 mar 2026 · NCT01587300

Resource Intervention to Support Equity (RISE) in High-Risk Neuroblastoma

  • Children's Healthcare of Atlanta, Atlanta
Reclutando
Hasta los 17 · Todos los sexos · Actualizado el 10 feb 2026 · NCT06831552

Allogeneic Expanded Gamma Delta T Cells With GD2 Chemoimmunotherapy in Relapsed /Refractory Neuroblastoma or Refractory/ Relapsed Osteosarcoma

  • Children's Healthcare of Atlanta, Atlanta
ReclutandoFase 1
12 Months · Todos los sexos · Actualizado el 26 dic 2025 · NCT05400603

De ClinicalTrials.gov, datos obtenidos el 1 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.